Menu

Vicore Pharma Holding AB (publ) VCRE

Full chart Compare
Set alert

Price alert · VCRE

All alert types
11.35 USD +0.07 (+0.62%)

At closeNov 10, 2026, 4:00 PM EST

11.35 0.00 0.00%

After hours · Nov 10, 4:00 PM ET

11.19 Day range 11.46
7.88 52-week range 17.80
YTD
-30.15%
1 year
-30.15%

Revenue & Expenses

Other Income → Expenses: $23.89MOther Operating Income → Expenses: $2.06MExpenses → Selling, General & Admin: $67.91MExpenses → Research & Development: $390.35MExpenses → Interest Expense: $48.98MGross Profit → Expenses: $3.82MRevenue → Gross Profit: $3.82MNet Loss → Expenses: $477.47MOther Income$23.89MOther Operating Income$2.06MGross Profit$3.82MNet Loss$477.47MExpenses$507.24MSelling, General & Admin$67.91MResearch & Development$390.35MInterest Expense$48.98MRevenue$3.82M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

VCRE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
3.82M109.35M0
414.89K9.91M0
3.82M109.35M0
456.20M303.54M321.51M
390.35M249.26M276.29M
67.91M50.44M44.59M
-452.39M-194.19M-321.51M
48.98M8.00K358.00K
-477.47M-168.63M-310.94M
-477.47M-168.63M-310.94M
-51.90M-15.29M-30.85M
-477.47M-168.63M-310.94M
-1.99-1.23-3.18
-0.216-0.112-0.315
-1.99-1.23-3.18
-428.50M-168.88M-310.97M
-46.58M-15.31M-30.85M
281.53M——